Chemical versus Mechanical and Chemical Venous Thromboembolism Prophylaxis in Neurocritically Ill Patients: A Cohort Study [0.03%]
神经重症患者静脉血栓栓塞症预防中化学方法与机械联合化学方法的比较：一项队列研究
Abdulrahman I Alshaya,Hayaa Alyahya,Reema Alzoman et al.
Abdulrahman I Alshaya et al.
Purpose: Patients admitted with neurocritical illness are presumed to be at high risk for venous thromboembolism (VTE). The administration of chemical and/or mechanical VTE prophylaxis is a common practice in critically i...
Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice [Response to Letter] [0.03%]
Acacia seyal树根的水甲醇粗提物和溶剂组分在小鼠中的止泻作用[回应信件]
Assefa Kebad Mengesha,Eshetie Melese Birru,Meaza Adugna
Assefa Kebad Mengesha
A Response to Article "Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice" [Letter] [0.03%]
对“Acacia Seyal (Fabaceae)根的抗甲醇粗提取物和溶剂组分在小鼠中的止泻活性”一文的回复[读者来信]
Novaria Sari Dewi Panjaitan,Fitriana Fitriana,Sarwo Handayani
Novaria Sari Dewi Panjaitan
Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice [0.03%]
Acacia seyal(豆科)根的水甲醇粗提取物和溶剂组分对小鼠的止泻作用
Assefa Kebad Mengesha,Eshetie Melese Birru,Meaza Adugna
Assefa Kebad Mengesha
Background: Traditionally, the root of Acacia seyal is used for the treatment of diarrhea. However, its efficacy has not been scientifically evaluated. Thus, this study aimed to validate the antidiarrheal activities using...
Fidaxomicin Use in the Pediatric Population with Clostridioides difficile [0.03%]
(fidaxomycin在儿科Clostridioides difficile患者中的使用)
Meredith B Oliver,Byron P Vaughn
Meredith B Oliver
Clostridioides difficile infection (CDI) remains a devastating infection both in hospital settings and in the community. While a number of antibiotics have anti-C. difficile activity, fidaxomicin is unique as a minimally absorbed antibiotic...
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response [0.03%]
检查点抑制剂相关心肌炎和皮质类固醇反应的神经网络模型预测
Filip Stefanovic,Andres Gomez-Caminero,David M Jacobs et al.
Filip Stefanovic et al.
Background: Serious but rare side effects associated with immunotherapy pose a difficult problem for regulators and practitioners. Immune checkpoint inhibitors (ICIs) have come into widespread use in oncology in recent ye...
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review [0.03%]
司美格鲁肽治疗肥胖的临床疗效及机制探讨
Nasser M Alorfi,Alanood S Algarni
Nasser M Alorfi
Purpose: Obesity and overweight pose a threat to health and are more common than undernutrition among adults. It is categorized by fat accumulation and a body mass index (BMI) of > 30. A significant increase in worldwide ...
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia [0.03%]
血管生成素样蛋白3(ANGPTL3)抑制剂在难治性高胆固醇血症管理中的应用
Constantine E Kosmas,Maria D Bousvarou,Andreas Sourlas et al.
Constantine E Kosmas et al.
Cardiovascular disease (CVD) is the most common cause of death in a global scale and significantly depends on the elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) and the subsequent formation of atherosclerotic plaques....
Jun Inaishi,Yoshifumi Saisho
Jun Inaishi
Exenatide is one of the exendin-based glucagon-like peptide 1 receptor agonists (GLP-1RAs) and is currently available in two formulations, ie, exenatide twice daily (BID), a short-acting GLP-1RA, and exenatide once weekly (QW), a long-actin...
Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019 [0.03%]
2019年苏丹喀土穆阿尔法赛尔眼科中心糖尿病性黄斑水肿抗VEGF治疗评估
Rayan Hamza Mohammed Ahmedalgabri,Tarig Omer,Fatima Zarroug et al.
Rayan Hamza Mohammed Ahmedalgabri et al.
Background: Anti-vascular endothelial growth factor (anti-VEGF) medicines have revolutionized DME and DR treatment. Despite the worldwide use of anti-VEGFs, their use remains limited in Sudan. This study aimed to assess t...